B · Normal
[Novartis AG’s third-quarter core earnings per share were US$2.46, exceeding market estimates] On October 27, Novartis AG’s third-quarter net sales were US$14.52 billion, US$14.46 billion expected; core operating profit was US$6.04 billion, US$5.61 billion expected; core earnings per share were US$2.46, US$2.28 expected.
Comments